Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

Global stocks recover some ground at end of turbulent week

Aug 19, 2019

LONDON — Global stock markets looked set to end a turbulent week on a positive note although worries about the U.S. economy and the trade conflict between the U.S. and China still have the potential to derail Friday's recovery. Investors in stocks were spooked earlier this week by developments in the U.S. bond market, which was pricing in a likely recession next year. Add in worries over the trade conflict between Washington and Beijing, Brexit, weak economic performance in Germany and political unrest in Hong Kong and stock markets have endured one of their worst weeks this year. On Friday,...

Crews race to ease pressure on damaged UK dam as rain looms

Aug 19, 2019

LONDON — Emergency crews in northwest England raced to pump water from a reservoir with a damaged dam Sunday as weather forecasts calling for thunderstorms hastened fear of the structure failing and flooding of a town. Firefighters said 22 high-capacity pumps were working around the clock to suck water out of the 180-year-old Toddbrook Reservoir to ease pressure on the dam, which was damaged when part of a spillway gave way in heavy rain last week. To repair a gaping hole, a Royal Air Force helicopter dropped one-ton bags of sand and gravel into the chasm. Workers on the ground...

Scientists say 10 warmest UK years have all been since 2002

Aug 19, 2019

LONDON — Britain's weather service says the country's 10 hottest years since the 19th century have all occurred since 2002, as climate change makes the U.K. warmer and wetter. The Met Office said in its State of the U.K. Climate report Wednesday that 2014 was the warmest year in records going back to 1884. The runners-up are 2006, 2011, 2007, 2017, 2003, 2018, 2004, 2002 and 2005. The 10 coldest years were all before 1964. Commenting on the report, published in the International Journal of Climatology, St. Andrews University climate scientist Michael Byrne said the trend was "hugely significant, though...

UK: Europe-led mission will protect vital shipping in Gulf

Aug 19, 2019

LONDON — Britain announced plans Monday to develop and deploy a Europe-led "maritime protection mission" to safeguard shipping in the vital Strait of Hormuz in light of Iran's seizure of a British-flagged tanker in the waterway last week. Briefing Parliament on the budding crisis, Foreign Secretary Jeremy Hunt accused Iran of "an act of state piracy" that must be met with a coordinated international reaction. Iranian officials have suggested the Stena Impero was seized and taken to an Iranian port in response to Britain's role in seizing an Iranian oil tanker two weeks earlier off the coast of Gibraltar, a...

British Airways, Lufthansa suspend Cairo flights

Aug 19, 2019

LONDON — British Airways and Lufthansa both said Saturday they were suspending flights to Cairo for unspecified reasons related to safety and security. The British carrier said it was canceling flights to the Egyptian capital for a week. The German airline said normal operations would resume Sunday. Both carriers delivered two-sentence statements via email. British Airways attributed its cancellations to what it called its constant review of security arrangements at all airports, calling them "a precaution to allow for further assessment." Lufthansa said it was suspending its flights as a precaution, mentioning "safety" but not "security" as its concern. Company...

Sign up now!